Tmd1 protein for treating bone loss diseases

The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).

Saved in:
Bibliographic Details
Main Authors HO, MEI LING, YEH, JWU LAI, SHI, GUEY YUEH, CHENG, CHIH KUANG, WU, HUA LIN
Format Patent
LanguageChinese
English
Published 11.02.2019
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).
Bibliography:Application Number: TW20176103272